Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F, Newell ML, Saba J, Gray G, Ndugwa Ch, Kilewo Ch, Massawe A, Kituuka P, Okong P, Grulich A, von Briesen H, Goudsmit J, Biberfeld G, Haverkamp G, Weverling GJ, Lange JM; Ghent Group on HIV in Women and Children.

AIDS. 2005 Nov 4;19(16):1865-75.

PMID:
16227795
2.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
3.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
4.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

5.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators.

J Infect Dis. 2003 Mar 1;187(5):725-35. Epub 2003 Feb 24.

6.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

7.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
8.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
9.

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study.

Kilewo C, Karlsson K, Massawe A, Lyamuya E, Swai A, Mhalu F, Biberfeld G; Mitra Study Team.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):315-23. doi: 10.1097/QAI.0b013e31816e395c.

PMID:
18344879
10.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
11.

18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.

Leroy V, Ekouevi DK, Becquet R, Viho I, Dequae-Merchadou L, Tonwe-Gold B, Rouet F, Sakarovitch C, Horo A, Timité-Konan M, Rouzioux C, Dabis F; ANRS 1201/1202 DITRAME PLUS Study Group.

PLoS One. 2008 Feb 20;3(2):e1645. doi: 10.1371/journal.pone.0001645.

12.

Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.

McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA.

PLoS Med. 2009 Oct;6(10):e1000172. doi: 10.1371/journal.pmed.1000172. Epub 2009 Oct 27.

13.

Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.

Pérez H, Vignoles M, Laufer N, Gómez A, Coll P, Lottner J, Rolón M, Salomón H, Cahn P.

Antivir Ther. 2008;13(1):135-9.

PMID:
18389908
14.

Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.

Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V; ANRS 1201/1202 DITRAME PLUS Study Group.

AIDS. 2005 Feb 18;19(3):309-18.

15.

[Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000].

Castetbon K, Leroy V, Spira R, Dabis F.

Sante. 2000 Mar-Apr;10(2):103-13. French.

PMID:
10960807
16.

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.

Gray GE, Urban M, Chersich MF, Bolton C, van Niekerk R, Violari A, Stevens W, McIntyre JA; PEP Study Group.

AIDS. 2005 Aug 12;19(12):1289-97.

PMID:
16052084
17.

Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000.

Dabis F, Leroy V, Castetbon K, Spira R, Newell ML, Salamon R.

AIDS. 2000 May 26;14(8):1017-26. Review.

PMID:
10853984
18.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(2):CD003510. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003510.

PMID:
12076484
19.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD003510.

PMID:
11869666
20.

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.

Leroy V, Montcho C, Manigart O, Van de Perre P, Dabis F, Msellati P, Meda N, You B, Simonon A, Rouzioux C; DITRAME Study Group.

AIDS. 2001 Mar 9;15(4):517-22.

PMID:
11242149
Items per page

Supplemental Content

Write to the Help Desk